1. Kim BS, Angthong W, Jeon YH, Semelka RC. Body MR imaging: fast, efficient, and comprehensive. Radiol Clin North Am. 2014; 52:623–636.
2. Semelka RC, Martin DR, Balci NC. Magnetic resonance imaging of the liver: how I do it. J Gastroenterol Hepatol. 2006; 21:632–637.
Article
3. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001; 218:27–38.
Article
4. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breathhold examination. Radiology. 1999; 212:876–884.
Article
5. Yu MH, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI. Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging. J Magn Reson Imaging. 2013; 38:1020–1026.
Article
6. Kim BS, Lee KR, Goh MJ. New imaging strategies using a motion-resistant liver sequence in uncooperative patients. Biomed Res Int. 2014; 2014:142658.
Article
7. Wright KL, Harrell MW, Jesberger JA, et al. Clinical evaluation of CAIPIRINHA: comparison against a GRAPPA standard. J Magn Reson Imaging. 2014; 39:189–194.
Article
8. Park YS, Lee CH, Kim IS, et al. Usefulness of controlled aliasing in parallel imaging results in higher acceleration in gadoxetic acid-enhanced liver magnetic resonance imaging to clarify the hepatic arterial phase. Invest Radiol. 2014; 49:183–188.
Article
9. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 2004; 230:266–275.
Article
10. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009; 29:1725–1748.
Article
11. Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics. 2011; 31:1547–1568.
Article
12. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K. Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol. 2011; 21:2336–2343.
13. Motosugi U, Ichikawa T, Tominaga L, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009; 19:2623–2629.
Article
14. Haradome H, Grazioli L, Al manea K, et al. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging. 2012; 35:132–139.
Article
15. Bashir MR, Husarik DB, Ziemlewicz TJ, Gupta RT, Boll DT, Merkle EM. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? J Magn Reson Imaging. 2012; 35:611–616.
Article
16. Bashir MR, Merkle EM. Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol. 2011; 21:291–294.
Article
17. Cho ES, Yu JS, Park AY, Woo S, Kim JH, Chung JJ. Feasibility of 5-minute delayed transition phase imaging with 30 degrees flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10 degrees flip angle. AJR Am J Roentgenol. 2015; 204:69–75.
18. Chang KJ, Kamel IR, Macura KJ, Bluemke DA. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008; 28:1983–1998.
Article
19. Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR. Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics. 2009; 29:1547–1563.
Article
20. Kim S, Mussi TC, Lee LJ, Mausner EV, Cho KC, Rosenkrantz AB. Effect of flip angle for optimization of image quality of gadoxetate disodium-enhanced biliary imaging at 1.5 T. AJR Am J Roentgenol. 2013; 200:90–96.
Article
21. Bashir MR, Breault SR, Braun R, Do RK, Nelson RC, Reeder SB. Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. Acad Radiol. 2014; 21:726–732.
Article
22. van Kessel CS, Veldhuis WB, van den Bosch MA, van Leeuwen MS. MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation. Eur Radiol. 2012; 22:2153–2160.
Article
23. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009; 192:1675–1681.
Article
24. Kim HY, Choi JY, Park CH, et al. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 2013; 48:1180–1187.
Article
25. Kanki A, Tamada T, Higaki A, et al. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. Magn Reson Imaging. 2012; 30:356–360.
Article